Pembrolizumab + Axitinib vs. Sunitinib: 5-Year RCC Survival & Biomarkers
The Shifting Sands of Disclosure: Navigating Competing Interests in Healthcare As an editor, I’ve seen firsthand the importance of transparency, especially when it comes to medical research. The document you provided highlights an essential but often complex area: competing interests. These disclosures, meticulously detailed, reveal the financial ties researchers have with pharmaceutical companies and other … Read more